CLCC1 Antikörper (N-Term)
-
- Target Alle CLCC1 Antikörper anzeigen
- CLCC1 (Chloride Channel CLIC-Like 1 (CLCC1))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Ratte, Maus, Hund
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLCC1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Spezifität
- CLCC1 antibody was raised against the N terminal of CLCC1
- Aufreinigung
- Purified
- Immunogen
- CLCC1 antibody was raised using the N terminal of CLCC1 corresponding to a region with amino acids MHYDAEIILKRETLLEIQKFLNGEDWKPGALDDALSDILINFKFHDFETW
- Top Product
- Discover our top product CLCC1 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
CLCC1 Blocking Peptide, catalog no. 33R-6106, is also available for use as a blocking control in assays to test for specificity of this CLCC1 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CLCC1 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- CLCC1 (Chloride Channel CLIC-Like 1 (CLCC1))
- Andere Bezeichnung
- CLCC1 (CLCC1 Produkte)
- Synonyme
- CLCC1 antikoerper, clcc1 antikoerper, MCLC antikoerper, Mclc antikoerper, chloride channel CLIC like 1 antikoerper, Chloride channel CLIC-like protein 1 antikoerper, chloride channel CLIC-like 1 antikoerper, chloride channel CLIC-like 1 S homeolog antikoerper, CLCC1 antikoerper, clcc1 antikoerper, Clcc1 antikoerper, clcc1.S antikoerper
- Hintergrund
- CLCC1 seems to act as a chloride ion channel.
- Molekulargewicht
- 61 kDa (MW of target protein)
- Pathways
- SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-